Drugs & Targets Lynparza gets FDA approval for first-line maintenance in BRCA-mutated advanced ovarian cancer January 04, 2019Vol.45 No.01
Drugs & Targets Sprycel approved in combination with chemo pediatric Ph+ ALL January 04, 2019Vol.45 No.01
Drugs & Targets Keytuda approved for recurrent locally advanced or metastatic MCC January 04, 2019Vol.45 No.01
Drugs & Targets Merck provides update on Keytruda sBLA for KEYNOTE-042 trial January 04, 2019Vol.45 No.01
Drugs & Targets FDA approves longer-acting calaspargase pegol-mknl for ALL January 04, 2019Vol.45 No.01
Drugs & Targets European Commission adopted positive opinion of rucaparib in platinum-based chemotherapy December 14, 2018Vol.44 No.46
Drugs & Targets FDA grants orphan drug designation to Merck’s M7824 in biliary tract cancer December 14, 2018Vol.44 No.46
